Randomized controlled trial comparing the therapeutic effects and safety of alogliptin and linagliptin in type 2 diabetic patients associated with diabetic nephropathy
Not Applicable
- Conditions
- type 2 diabetic patients associated with diabetic nephropathy
- Registration Number
- JPRN-UMIN000015811
- Lead Sponsor
- agoya City West Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who has a history of hypersensitivity 2)Pregnant or possibly pregnant women and women on lactation 3)Ineligible patients according to the investigator's judgement 4)The patients who do not agree with this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method glycoalbumin
- Secondary Outcome Measures
Name Time Method Hemoglobin A1c, 1,5-anhydroglucitol, adverse event